Meet Floriane Ashraf: A Pioneer in Pharmacy and Winner of Paris’ Best Thesis Award
By Malak Khaled
Dr. Floriane Ashraf Ishaq has etched her name in history as the first Egyptian to receive the prestigious “Prix Solennel de Thèse de la Chancellerie des Universités de Paris” for her PhD in pharmacy.
This honor is awarded to the most outstanding doctoral theses across Paris universities. Floriane won the award based on the significant impact her groundbreaking research has left on the field of pharmacy.
What Is Floriane’s Thesis About?
Dr. Floriane’s PhD thesis is titled “MGlu Receptor-Targeted Nanobodies as Innovative Agents for the Treatment of Schizophrenia.” Her research focuses on using nanobodies to target brain receptors, a pioneering approach to treating schizophrenia, a complex mental disorder that impacts millions worldwide.
Why Is Floriane Ashraf’s Thesis Revolutionary?
Schizophrenia is one of the most challenging mental health conditions to diagnose and treat. It is a severe mental disorder that disrupts a person’s ability to think clearly, manage emotions, and interact with others, often involving hallucinations or delusions.
Dr. Floriane’s work leverages computer-aided drug design to develop advanced therapies, offering new hope for patients and addressing critical gaps in mental health treatment.
Floriane Ashraf’s Post-Graduate Path
Floriane pursued postgraduate studies in France, earning her master’s degree with distinction in drug design using computer technology from Paris Diderot University in 2020.
Then, she completed her PhD at Paris Cité University. Her dedication to advancing drug discovery has earned her multiple awards and invitations to international scientific conferences.
An Inspiration for Generations
Dr. Floriane Ashraf Ishaq’s accomplishments highlight the power of scientific innovation to improve lives. And her success is proof of her commitment to leaving a lasting global impact.
WE ALSO SAID: Don’t Miss…Success Stories of Leading Women: Pioneers of the Health Industry in the Middle East
